Clinical Significance of Peripheral Blood Erythroblastosis after Hematopoietic Stem Cell Transplantation

Susumu Goyama Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Yoshinobu Kanda Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Yasuhito Nannya Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Seishi Ogawa Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Yuki Asano-Moki Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Natsu Ogawa Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Masahiro Nakagawa Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Mamiko Sakata-Yanagimoto Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Masahito Kawazu Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

Yukiko Komeno Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Yoichi Imai Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Akira Hangaishi Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Mineo Kurokawa Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Shiho Tsujino Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Katsunori Aoki Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Shigeru Chiba Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Toru Motokura Department of Hematology & Oncology University of Tokyo Hospital Tokyo Japan

Hisamaru Hirai Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital Tokyo Japan

References